betahistine has been researched along with Schizophrenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
| Davis, JM; Jin, H; Jing, Z; Maayan, L; Meyers, J; Sershen, H; Smith, RC; Szabo, V; Wu, R; Youssef, M; Zhao, J | 1 |
| Albeck, JH; Barak, N; Beck, Y | 1 |
| Fuchs, C; Levi, A; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Levi, A; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
1 review(s) available for betahistine and Schizophrenia
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |
4 trial(s) available for betahistine and Schizophrenia
| Article | Year |
|---|---|
Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Betahistine; Body Mass Index; Body Weight; Child; Clozapine; Double-Blind Method; Female; Histamine Agonists; Humans; Male; Olanzapine; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2018 |
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Double-Blind Method; Drug Therapy, Combination; Female; Histamine Agonists; Humans; Internationality; Male; Olanzapine; Pilot Projects; Psychotic Disorders; Schizophrenia; Weight Gain; Young Adult | 2016 |
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Double-Blind Method; Female; Histamine Agonists; Humans; Male; Middle Aged; Morpholines; Olanzapine; Reboxetine; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2013 |
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Body Mass Index; Body Weight; Histamine Agonists; Histamine Antagonists; Humans; Olanzapine; Receptors, Histamine H3; Schizophrenia; Weight Gain | 2005 |